Edition:
India

Apollo Endosurgery Inc (APEN.OQ)

APEN.OQ on NASDAQ Stock Exchange Global Market

8.28USD
20 Jul 2018
Change (% chg)

$0.18 (+2.22%)
Prev Close
$8.10
Open
$8.06
Day's High
$8.45
Day's Low
$8.00
Volume
11,846
Avg. Vol
13,908
52-wk High
$9.56
52-wk Low
$3.60

Latest Key Developments (Source: Significant Developments)

Apollo Endosurgery Announces Pricing Of $20.6 Million Public Offering Of Common Stock
Wednesday, 20 Jun 2018 

June 20 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY, INC. ANNOUNCES PRICING OF $20.6 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 3.75 MILLION COMMON SHARES PRICED AT $5.50PER SHARE.  Full Article

Apollo Endosurgery Announces Approval Orbera365 In Saudi Arabia
Tuesday, 24 Apr 2018 

April 23 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY ANNOUNCES APPROVAL OF THE NEW 12-MONTH WEIGHT LOSS BALLOON - ORBERA365™ - IN THE KINGDOM OF SAUDI ARABIA.APOLLO ENDOSURGERY INC - SAUDI FOOD AND DRUG AUTHORITY APPROVED ORBERA365 MANAGED WEIGHT LOSS SYSTEM & ISSUED MEDICAL DEVICE MARKETING AUTHORIZATION.APOLLO ENDOSURGERY INC - MDMA ALLOWS CO TO MARKET ORBERA365 IN KINGDOM OF SAUDI ARABIA WITH ITS EXCLUSIVE DISTRIBUTION PARTNER, AL-NOZHA MEDICAL.  Full Article

Apollo Endosurgery Inc Files For Stock Shelf Of Upto $50 Million - SEC Filing ‍​
Tuesday, 5 Dec 2017 

Dec 4 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY INC FILES FOR STOCK SHELF OF UPTO $50 MILLION - SEC FILING ‍​.  Full Article

Apollo Endosurgery Receives FDA Clearance For Overstitch Sx Endoscopic Suturing System
Tuesday, 28 Nov 2017 

Nov 27 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY RECEIVES FDA CLEARANCE FOR OVERSTITCH™ SX ENDOSCOPIC SUTURING SYSTEM.APOLLO ENDOSURGERY INC - ‍U.S. FOOD AND DRUG ADMINISTRATION 510K CLEARANCE OF OVERSTITCH SX​.APOLLO ENDOSURGERY INC - ‍PLANS TO INTRODUCE SX SYSTEM IN US AND EUROPE IN FIRST HALF OF 2018​.  Full Article

Apollo Endosurgery reports qtrly loss per share $‍0.32​
Friday, 27 Oct 2017 

Oct 26 (Reuters) - Apollo Endosurgery Inc :Apollo Endosurgery Inc reports third quarter 2017 results.Q3 sales $16.5 million versus I/B/E/S view $16.7 million.Apollo Endosurgery Inc - qtrly loss per share $‍0.32​.  Full Article

Lpath files for mixed shelf of up to $10 mln - SEC filing
Tuesday, 23 Aug 2016 

Lpath Inc :Files for mixed shelf of up to $10 million - SEC filing.  Full Article

BRIEF-Apollo Endosurgery Q4 Loss Per Share $0.42

* APOLLO ENDOSURGERY, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS